Daniel J. Lippis sold $87k of EW
CVP, TAVR at Edwards Lifesciences Corp. 1,019 shares at an average of $85.38, traded Mar 11, 2026, filed Mar 11, 2026.
Score components
- +15RoleOfficer
- +9Trade size$87k at market
- 0Share of holdings soldSold 2.9% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001225208-26-003538, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 11, 2026 | MOption exercise Common Stock10b5-1 | +1,019 | $59.26 | $60k | 34,953 | Mar 11, 2026 |
| Mar 11, 2026 | SOpen-market sale Common Stock10b5-1 | -1,019 | $85.38 | $87k | 33,934 | Mar 11, 2026 |
| Mar 11, 2026 | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -1,019 | $0.00 | $0 | 3,057 | Mar 11, 2026 |
Related signals
Other insiders at Edwards Lifesciences Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Edwards Lifesciences Corp | Daniel J. Lippis CVP, TAVR | $53k 619 shares | -2% | |
| 0Weak | Edwards Lifesciences Corp | Daniel J. Lippis CVP, TAVR | $54k 619 shares | -2% | |
| 37Weak | Edwards Lifesciences Corp | Andrew M. Dahl SVP, Corporate Controller | $49k 568 shares | -4% | |
| 60Notable | Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $2.0M 23,145 shares | -19% | |
| 41Moderate | Edwards Lifesciences Corp | Daveen Chopra CVP, TMTT & Surgical | $127k 1,500 shares | -3% | |
| 75Notable | Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $1.5M 17,968 shares | -55% | |
| 25Weak | Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $1.8M 22,680 shares | -52% | |
| 32Weak | Edwards Lifesciences Corp | Scott B. Ullem CVP, Chief Financial Officer | $1.1M 13,000 shares | -25% | |
| 30Weak | Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $974k 11,340 shares | -35% | |
| 75Notable | Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $2.0M 24,000 shares | -53% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.